Our Commitment
Precision Therapeutics is dedicated to improving the outcomes of cancer patients by providing personalized medicine solutions that aim to increase quality of life and cancer survival rates.
Introducing a way to help treat
cancer without a single patient side effect.
And even more amazingly, without a single patient.
With the ChemoFx
® Drug Response Marker, you can determine how chemotherapy will impact cancer cells before it impacts cancer patients. This simple test determines how a patient’s particular cells respond to different chemotherapies in the lab—not in the patient.